Abstract:A significant challenge facing tissue engineers is the design and development of complex multitissue systems, including vascularized tissue-tissue interfaces. While conventional in vitro models focus on either vasculogenesis (de novo formation of blood vessels) or angiogenesis (vessels sprouting from existing vessels or endothelial monolayers), successful therapeutic vascularization strategies will likely rely on coordinated integration of both processes. To address this challenge, we developed a novel in vitro multitissue interface model in which human endothelial colony forming cell (ECFC)-encapsulated tissue spheres are embedded within a surrounding tissue microenvironment. This highly reproducible approach exploits biphilic surfaces (nanostructured surfaces with distinct superhydrophobic and hydrophilic regions) to (i) support tissue compartments with user-specified matrix composition and physical properties as well as cell type and density and (ii) introduce boundary conditions that prevent the cell-mediated tissue contraction routinely observed with conventional three-dimensional monodispersion cultures. This multitissue interface model was applied to test the hypothesis that independent control of cell-extracellular matrix (ECM) and cell-cell interactions would affect vascularization within the tissue sphere as well as across the tissue-tissue interface. We found that high-cell-density tissue spheres containing 5 × 10(6) ECFCs/mL exhibit rapid and robust vasculogenesis, forming highly interconnected, stable (as indicated by type IV collagen deposition) vessel networks within only 3 days. Addition of adipose-derived stromal cells (ASCs) in the surrounding tissue further enhanced vasculogenesis within the sphere as well as angiogenic vessel elongation across the tissue-tissue boundary, with both effects being dependent on the ASC density. Overall, results show that the ECFC density and ECFC-ASC crosstalk, in terms of paracrine and mechanophysical signaling, are critical determinants of vascularization within a given tissue compartment and across tissue interfaces. This new in vitro multitissue interface model and the associated mechanistic insights it yields provide guiding principles for the design and optimization of multitissue vascularization strategies for research and clinical applications.

A Novel in Vitro Angiogenesis Model Based on a Microfluidic Device

Microfluidic Model to Mimic Initial Event of Neovascularization

Biomimetic Tumor-Induced Angiogenesis and Anti-Angiogenic Therapy in A Microfluidic Model

On-chip-angiogenesis Based on a High-Throughput Biomimetic Three-Dimensional Cell Spheroid Culture System.

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

A Novel Tissue Model for Angiogenesis: Evaluation of Inhibitors or Promoters in Tissue Level

Angiogenesis and Functional Vessel Formation Induced by Interstitial Flow and Vascular Endothelial Growth Factor Using a Microfluidic Chip

Human Ocular Angiogenesis‐Inspired Vascular Models on an Injection‐Molded Microfluidic Chip

A Perforated Microhole-Based Microfluidic Device for Improving Sprouting Angiogenesis in Vitro

Long-term cultured microvascular networks on chip for tumor vascularization research and drug testing

Microfluidic-Based 3D Engineered Microvascular Networks and Their Applications in Vascularized Microtumor Models

Falsifying computational models of angiogenesis through quantitative comparison with in vitro models

Replacement in angiogenesis research: Studying mechanisms of blood vessel development by animal-free in vitro, in vivo and in silico approaches

In Vitro Multitissue Interface Model Supports Rapid Vasculogenesis and Mechanistic Study of Vascularization Across Tissue Compartments

A Potential in Vitro 3D Cell Model to Study Vascular Diseases by Simulating the Vascular Wall Microenvironment and Its Application

Angiogenic responses in a 3D micro-engineered environment of primary endothelial cells and pericytes

Establishment and characterization of a novel in vitro angiogenesis model using a microvascular endothelial cell line, F-2C, cultured in chemically defined medium

A Novel Xenograft Model In Zebrafish For High-Resolution Investigating Dynamics Of Neovascularization In Tumors

Improvement of Tube Formation Model of Cell: Application for Acute Hypoxia in in Vitro Study of Angiogenesis

Endothelialized microrods for minimally invasive <i>in situ</i> neovascularization.

A critical analysis of current in vitro and in vivo angiogenesis assays